Multilevel mobile health approach to improve cardiovascular health in resource-limited communities with Step It Up: a randomised controlled trial protocol targeting physical activity
Authors:
- Kosuke TamuraKTKosuke Tamura
- Nithya P VijayakumarNVNithya P Vijayakumar
- James F TroendleJTJames F Troendle
- Kaveri CurlinKCKaveri Curlin
- Sam J NeallySNSam J Neally
- Valerie M MitchellVMValerie M Mitchell
- Billy S CollinsBCBilly S Collins
- Yvonne BaumerYBYvonne Baumer
- Cristhian A Gutierrez-HuertaCGCristhian A Gutierrez-Huerta
- Briana S TurnerBTBriana S Turner
- Marcus R AndrewsMAMarcus R Andrews
Open Access
Abstract
Introduction Although physical activity (PA) reduces cardiovascular disease (CVD) risk, physical inactivity remains a pressing public health concern, especially among African American (AA) women in the USA. PA interventions focused on AA women living in resource-limited communities with scarce PA infrastructure are needed. Mobile health (mHealth) technology can increase access to PA interventions. We describe the development of a clinical protocol for a multilevel, community-based, mHealth PA intervention for AA women. Methods and analysis An mHealth intervention targeting AA women living in resource-limited Washington, DC communities was developed based on the socioecological framework for PA. Over 6 months, we will use a Sequential Multi-Assignment, Randomized Trial approach to compare the effects on PA of location-based remote messaging (named ‘tailored-to-place’) to standard remote messaging in an mHealth intervention. Participants will be randomised to a remote messaging intervention for 3 months, at which point the intervention strategy will adapt based on individuals’ PA levels. Those who do not meet the PA goal will be rerandomised to more intensive treatment. Participants will be followed for another 3 months to determine the contribution of each mHealth intervention to PA level. This protocol will use novel statistical approaches to account for the adaptive strategy. Finally, effects of PA changes on CVD risk biomarkers will be characterised. Ethics and dissemination This protocol has been developed in partnership with a Washington, DC-area community advisory board to ensure feasibility and acceptability to community members. The National Institutes of Health Intramural IRB approved this research and the National Heart, Lung, and Blood Institute provided funding. Once published, results of this work will be disseminated to community members through presentations at community advisory board meetings and our quarterly newsletter. Trial registration number NCT03288207.Keywords
This publication has 68 references indexed in Scilit:
- IL-1Β Enriched Monocytes Mount Massive IL-6 Responses to Common Inflammatory Triggers among Chronically HIV-1 Infected Adults on Stable Anti-Retroviral Therapy at Risk for Cardiovascular DiseasePLOS ONE, 2013
- Obesity and Black Women: Special Considerations Related to Genesis and Therapeutic ApproachesCurrent Cardiovascular Risk Reports, 2013
- Relationship between perceptions about neighborhood environment and prevalent obesity: data from the dallas heart studyObesity, 2012
- Electronic feedback in a diet- and physical activity-based lifestyle intervention for weight loss: a randomized controlled trialInternational Journal of Behavioral Nutrition and Physical Activity, 2011
- The Built Environment and Location-Based Physical ActivityAmerican Journal of Preventive Medicine, 2010
- Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- The Multiphase Optimization Strategy (MOST) and the Sequential Multiple Assignment Randomized Trial (SMART)American Journal of Preventive Medicine, 2007
- Descriptive Characteristics of the Dietary Patterns Used in the Dietary Approaches to Stop Hypertension TrialJournal of the American Dietetic Association, 1999
- Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjectsThe Journal of Clinical Endocrinology & Metabolism, 1995